Scottish startup 1nhaler secures £2.2M to replace bulky plastic inhalers with cardboard
1inhaler, led by Archangels alongside Scottish Enterprise and BBB Investments, is advancing its single-dose DPI platform toward regulatory approval. The novel inhaler is made predominantly from cardboard, sized like a credit card, and transforms into a 3D device for patient use. The technology addresses limitations in accessibility, cost, and environmental impact compared to conventional plastic inhalers. Beyond respiratory conditions like asthma and COPD, the platform could deliver dry powder medicines for pain relief and vaccines.
Key points
- £2.2M funding for cardboard-based inhaler development toward regulatory approval
- Credit-card-sized device that transforms into 3D inhaler with fewer components
- Designed for lower manufacturing costs and environmental benefits versus plastic inhalers
Summary and key points written by AI from the headline and a short excerpt, so they can be incomplete or wrong. Tech.eu did the reporting; read the original for the full story.
Read the full story at Tech.eu
